McKesson (NYSE: MCK) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q4), McKesson missed estimates on revenues and whiffed on earnings per share.

Compared to the prior-year quarter, revenue contracted. Non-GAAP earnings per share shrank significantly. GAAP earnings per share dropped significantly.

Gross margins grew, operating margins were steady, net margins contracted.

Revenue details
McKesson logged revenue of $30.62 billion. The 13 analysts polled by S&P Capital IQ expected a top line of $32.01 billion on the same basis. GAAP reported sales were the same as the prior-year quarter's.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.45. The 16 earnings estimates compiled by S&P Capital IQ averaged $2.30 per share. Non-GAAP EPS of $1.45 for Q4 were 31% lower than the prior-year quarter's $2.09 per share. GAAP EPS of $1.10 for Q4 were 47% lower than the prior-year quarter's $2.08 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 6.5%, 70 basis points better than the prior-year quarter. Operating margin was 2.1%, much about the same as the prior-year quarter. Net margin was 0.8%, 80 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $32.62 billion. On the bottom line, the average EPS estimate is $1.66.

Next year's average estimate for revenue is $131.25 billion. The average EPS estimate is $8.01.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 617 members out of 644 rating the stock outperform, and 27 members rating it underperform. Among 221 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 213 give McKesson a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $117.23.

Is McKesson the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.